by Backoffice | Jan 14, 2020 | Trial results
The clinical phase I study evaluated the safety and feasibility of injecting allogeneic adipose-derived mesenchymal stem cells (ASCs) into the lacrimal gland as a treatment of aqueous deficient dry eye disease (ADDE) Sjögrens syndrome. The study found injection of...
